Neurologic Disorders Therapeutics Market Overview, Growth, and Trends (2021-2031)

MARKET INTRODUCTION

A neurological disorder is medical complication that affects the nervous system that includes brain, spinal cord, and other nerves. Symptoms of a neurological disorder are possibly mild, such as muscle weakness, poor coordination, or changes in thinking patterns. As per the World Health Organization (WHO), the cerebrovascular diseases are the common cause of concern for several patients.

MARKET DYNAMICS

The neurologic disorders therapeutics market is driving due to the rising prevalence of neurological diseases coupled with increasing awareness associated with the disease diagnosis. However, lack of adoption in emerging countries is expected to hamper the growth of the global neurologic disorder therapeutics market. Moreover, availability of advanced diagnostic techniques, and the approval of novel drugs is anticipated to drive demand the growth of the market.

MARKET SCOPE

The "Neurologic Disorders Therapeutics Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of neurologic disorders therapeutics market with detailed market segmentation by indication, drug class and application. The neurologic disorders therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Neurologic Disorders Therapeutics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The neurologic disorders therapeutics market is segmented based on indication, drug class and application. On the basis of indication, the market is segmented into Parkinson diseases, Alzheimer diseases, psychotic disorders, epileptic disorders, autism disorders, and brain tumor diseases. Based on drug class, the market is segmented into, ACE inhibitors, NMDA antagonist, D2 antagonists, Others. On the basis of application, the market is segmented into, central nervous system (CNS), and peripheral nervous system (PNS).
?

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the neurologic disorders therapeutics market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neurologic disorders therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting neurologic disorders therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the neurologic disorders therapeutics market in these regions.

MARKET PLAYERS

The report covers key developments in the neurologic disorders therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from neurologic disorders therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for neurologic disorders therapeutics market in the global market. Below mentioned is the list of few companies engaged in the neurologic disorders therapeutics market.

The report also includes the profiles of key players in neurologic disorders therapeutics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   Biogen Inc.
  
•   F. Hoffmann-La Roche Ltd.
  
•   Johnson & Johnson Services Inc.
  
•   Novartis AG
  
•   Pfizer Inc.
  
•   Sage Therapeutics, Inc
  
•   Boehringer Ingelheim International GmbH
  
•   Bayer AG
  
•   GlaxoSmithKline plc
  
•   Neurona Therapeutics
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Neurologic Disorders Therapeutics Report Scope